Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphomaZijun Y. Xu‐Monette, Ken H. Young, Ling Li et al.|Blood|2016Cited by 109
Clinical and biological significance of<i>de novo</i>CD5+ diffuse large B-cell lymphoma in Western countriesZijun Y. Xu‐Monette, Ken H. Young, Alexandar Tzankov et al.|Oncotarget|2015Cited by 93
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell LymphomaXiaoxiao Wang, Ken H. Young, Xin Cao et al.|Neoplasia|2018Cited by 64
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Ken H. Young, Zijun Y. Xu‐Monette et al.|American Journal Of Pathology|2017Cited by 60
Focal Segmental Glomerulosclerosis (FSGS) Progressing to Collapsing Glomerulopathy in Renal Transplant Recipients With and Without COVID-19 Infection.Christopher A Thorburn, Ping L. Zhang, Dilip Samarapungavan et al.|Transplantation Proceedings|2022Cited by 8